$2.32T
Total marketcap
$109.5B
Total volume
BTC 50.05%     ETH 15.41%
Dominance

Vivos RDGL Stock

0.1 USD {{ price }} -3.601107% {{change_pct}}%
Exchange
Other OTC
Market Cap
40.7M USD
LOW - HIGH [24H]
0.1 - 0.11 USD
VOLUME [24H]
3.31M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.01 USD

Vivos Price Chart

Vivos RDGL Financial and Trading Overview

Vivos stock price 0.1 USD
Previous Close 0.06 USD
Open 0.06 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0.05 - 0.06 USD
52 Week Range 0.04 - 0.12 USD
Volume 392.76K USD
Avg. Volume 659.06K USD
Market Cap 19.64M USD
Beta (5Y Monthly) 1.686619
PE Ratio (TTM) N/A
EPS (TTM) -0.01 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

RDGL Valuation Measures

Enterprise Value 29.29M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 665.74207
Price/Book (mrq) N/A
Enterprise Value/Revenue 993.021
Enterprise Value/EBITDA N/A

Trading Information

Vivos Stock Price History

Beta (5Y Monthly) 1.686619
52-Week Change -30.26%
S&P500 52-Week Change 20.43%
52 Week High 0.12 USD
52 Week Low 0.04 USD
50-Day Moving Average 0.07 USD
200-Day Moving Average 0.06 USD

RDGL Share Statistics

Avg. Volume (3 month) 659.06K USD
Avg. Daily Volume (10-Days) 369.23K USD
Shares Outstanding 370.54M
Float 351.17M
Short Ratio N/A
% Held by Insiders 5.35%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:8

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -6842.85%
Gross Margin -12.93%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -91.10%
Return on Equity (ttm) -153.20%

Income Statement

Revenue (ttm) 29.5K USD
Revenue Per Share (ttm) 0 USD
Quarterly Revenue Growth (yoy) -53.80%
Gross Profit (ttm) 7.72K USD
EBITDA N/A
Net Income Avi to Common (ttm) -2018574 USD
Diluted EPS (ttm) -0.01
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 1.41M USD
Total Cash Per Share (mrq) 0.004 USD
Total Debt (mrq) 0 USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 29.838
Book Value Per Share (mrq) -0.023

Cash Flow Statement

Operating Cash Flow (ttm) -1029385 USD
Levered Free Cash Flow (ttm) -321662 USD

Profile of Vivos

Country United States
State WA
City Richland
Address 719 Jadwin Avenue
ZIP 99352
Phone 509 736 4000
Website https://www.radiogel.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 1

Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States and internationally. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.

Q&A For Vivos Stock

What is a current RDGL stock price?

Vivos RDGL stock price today per share is 0.1 USD.

How to purchase Vivos stock?

You can buy RDGL shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Vivos?

The stock symbol or ticker of Vivos is RDGL.

Which industry does the Vivos company belong to?

The Vivos industry is Medical Devices.

How many shares does Vivos have in circulation?

The max supply of Vivos shares is 389.89M.

What is Vivos Price to Earnings Ratio (PE Ratio)?

Vivos PE Ratio is now.

What was Vivos earnings per share over the trailing 12 months (TTM)?

Vivos EPS is -0.01 USD over the trailing 12 months.

Which sector does the Vivos company belong to?

The Vivos sector is Healthcare.